Ascentage 药

最新新闻

• 评级变动
  BTIG Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Maintains Target Price $50
  \u5e02\u573a\u8d44\u8baf · 2025/12/4
• Oppenheimer Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Maintains Target Price $45
  \u5e02\u573a\u8d44\u8baf · 2026/8/21
• 评级变动
  Truist Financial Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Maintains Target Price $51
  \u5e02\u573a\u8d44\u8baf · 2026/3/27
• B. Riley Securities Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Maintains Target Price $45
  \u5e02\u573a\u8d44\u8baf · 2026/9/2
• Analysts Offer Insights on NA Companies: Ascentage Pharma Group International Unsponsored ADR (AAPG), Fatpipe, Inc. (FATN) and Aptera Motors Corp. Class B (SEV)
  TipRanks · 2026/8/21
• 评级变动
  BTIG Initiates Ascentage Pharma(AAPG.US) With Buy Rating, Announces Target Price $50
  \u5e02\u573a\u8d44\u8baf · 2025/11/10
• 评级变动
  Truist Financial Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Cuts Target Price to $22.34
  \u5e02\u573a\u8d44\u8baf · 2026/4/24
• BTIG Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Maintains Target Price $48
  \u5e02\u573a\u8d44\u8baf · 2026/8/21
• 评级变动
  J.P. Morgan Maintains Ascentage Pharma(AAPG.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2025/8/22
• 评级变动
  J.P. Morgan Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Cuts Target Price to $46
  \u5e02\u573a\u8d44\u8baf · 2026/4/16
• 评级变动
  Lucid Capital Initiates Ascentage Pharma(AAPG.US) With Buy Rating, Announces Target Price $50
  \u5e02\u573a\u8d44\u8baf · 2025/12/15
• 评级变动
  Piper Sandler Initiates Ascentage Pharma(AAPG.US) With Buy Rating, Announces Target Price $48
  \u5e02\u573a\u8d44\u8baf · 2025/11/5
• 评级变动
  Deutsche Bank Initiates Ascentage Pharma(AAPG.US) With Buy Rating, Announces Target Price $40
  \u5e02\u573a\u8d44\u8baf · 2026/4/24
• Truist Financial Maintains Ascentage Pharma(AAPG.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/8/21
• 评级变动
  BTIG Initiates Ascentage Pharma(AAPG.US) With Buy Rating, Announces Target Price $48
  \u5e02\u573a\u8d44\u8baf · 2026/3/12
• 评级变动
  B. Riley Securities Initiates Ascentage Pharma(AAPG.US) With Buy Rating, Announces Target Price $45
  \u5e02\u573a\u8d44\u8baf · 2026/6/10
• 评级变动
  Piper Sandler Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Maintains Target Price $48
  \u5e02\u573a\u8d44\u8baf · 2026/6/1
• 评级变动
  J.P. Morgan Initiates Ascentage Pharma(AAPG.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2025/7/28
• 评级变动
  Oppenheimer Initiates Ascentage Pharma(AAPG.US) With Buy Rating, Announces Target Price $45
  \u5e02\u573a\u8d44\u8baf · 2026/6/15
• 评级变动
  J.P. Morgan Sticks to Their Buy Rating for Ascentage Pharma Group International Unsponsored ADR (AAPG)
  TipRanks · 2025/8/22

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。